Globeflex Capital’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,260
| Closed | -$105K | – | 441 |
|
|
2025
Q2 | $105K | Hold |
1,260
| – | – | 0.01% | 371 |
|
|
2025
Q1 | $106K | Hold |
1,260
| – | – | 0.01% | 382 |
|
|
2024
Q4 | $116K | Hold |
1,260
| – | – | 0.01% | 372 |
|
|
2024
Q3 | $117K | Hold |
1,260
| – | – | 0.01% | 368 |
|
|
2024
Q2 | $104K | Buy |
+1,260
| New | +$92.6K | 0.01% | 371 |
|
|
2020
Q2 | – | Sell |
-6,578
| Closed | -$164K | – | 560 |
|
|
2020
Q1 | $164K | Hold |
6,578
| – | – | 0.05% | 383 |
|
|
2019
Q4 | $236K | Hold |
6,578
| – | – | 0.04% | 407 |
|
|
2019
Q3 | $225K | Hold |
6,578
| – | – | 0.05% | 381 |
|
|
2019
Q2 | $184K | Hold |
6,578
| – | – | 0.04% | 390 |
|
|
2019
Q1 | $204K | Buy |
6,578
+1,378
| +27% | +$36.8K | 0.04% | 373 |
|
|
2018
Q4 | $123K | Sell |
5,200
-10,700
| -67% | -$292K | 0.03% | 396 |
|
|
2018
Q3 | $616K | Buy |
15,900
+1,300
| +9% | +$46.8K | 0.12% | 267 |
|
|
2018
Q2 | $489K | Buy |
14,600
+2,300
| +19% | +$81.8K | 0.1% | 306 |
|
|
2018
Q1 | $446K | Buy |
12,300
+4,356
| +55% | +$151K | 0.09% | 308 |
|
|
2017
Q4 | $253K | Sell |
7,944
-70,133
| -90% | -$2.4M | 0.07% | 288 |
|
|
2017
Q3 | $2.92M | Sell |
78,077
-3,900
| -5% | -$133K | 0.83% | 10 |
|
|
2017
Q2 | $2.56M | Sell |
81,977
-6,200
| -7% | -$179K | 0.63% | 18 |
|
|
2017
Q1 | $2.17M | Sell |
88,177
-3,300
| -4% | -$77.5K | 0.51% | 30 |
|
|
2016
Q4 | $2.32M | Sell |
91,477
-1,100
| -1% | -$24.4K | 0.58% | 19 |
|
|
2016
Q3 | $1.84M | Buy |
92,577
+16,375
| +21% | +$286K | 0.46% | 36 |
|
|
2016
Q2 | $1.09M | Sell |
76,202
-30
| -0% | -$459 | 0.3% | 123 |
|
|
2016
Q1 | $1.18M | Buy |
76,232
+58
| +0.1% | +$832 | 0.32% | 99 |
|
|
2015
Q4 | $1.31M | Sell |
76,174
-2,700
| -3% | -$39.1K | 0.35% | 82 |
|
|
2015
Q3 | $961K | Buy |
78,874
+78,800
| +106,486% | +$1.01M | 0.21% | 166 |
|
|
2015
Q2 | $1K | Hold |
74
| – | – | ﹤0.01% | 446 |
|
|
2015
Q1 | $1K | Sell |
74
-28
| -27% | -$220 | ﹤0.01% | 448 |
|
|
2014
Q4 | $1K | Sell |
102
-17
| -14% | -$122 | ﹤0.01% | 444 |
|
|
2014
Q3 | $1K | Sell |
119
-38
| -24% | -$284 | ﹤0.01% | 462 |
|
|
2014
Q2 | $1K | Sell |
157
-32
| -17% | -$250 | ﹤0.01% | 505 |
|
|
2014
Q1 | $1K | Hold |
189
| – | – | ﹤0.01% | 524 |
|
|
2013
Q4 | $1K | Hold |
189
| – | – | ﹤0.01% | 522 |
|
|
2013
Q3 | $1K | Hold |
189
| – | – | ﹤0.01% | 510 |
|
|
2013
Q2 | $1K | Buy |
+189
| New | +$1.19K | ﹤0.01% | 508 |
|
Other funds holding LMAT
CCA
CCM
GCM
CAM
Globeflex Capital's LMAT Position: Q3 2025 in Review
Globeflex Capital sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 1,260 shares — an estimated $105K sold.
Globeflex Capital first reported a position in LMAT in Q2 2013 and held it in 33 quarters. The position peaked at $2.92M in Q3 2017. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.
- Globeflex Capital reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
- Globeflex Capital sold 1,260 LeMaitre Vascular shares in Q3 2025, an estimated $105K.
- Globeflex Capital first reported a position in LeMaitre Vascular in Q2 2013 and held it in 33 quarters.
- Globeflex Capital's LeMaitre Vascular position peaked at $2.92M in Q3 2017.
- 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.
Based on Globeflex Capital's 13F filing for Q3 2025, filed 12 Nov 2025.